Andrew O'Connor

Andrew O'Connor is a dedicated engineer and technical leader currently serving as a Board Observer for multiple companies, including kea and Robigo. With experience as a VC Summer Associate at In-Q-Tel and prior roles such as COO at Alveolus Bio and ResBiotic, they have a strong foundation in the intersection of technology, investment, and health innovation. Andrew is actively pursuing advanced degrees at Harvard Business School and Harvard's School of Engineering and Applied Sciences, complementing their Bachelor of Chemical Engineering from Auburn University. Passionate about technology's role in enhancing lives, they focus on investing in early-stage companies across various sectors including climate tech and AI.